We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$16.3B
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
-4.64%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$6.01B
AUM Growth
-$362M
(-5.7%)
Cap. Flow
+$68.7M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
34.55%
Holding
1,204
New
32
Increased
655
Reduced
474
Closed
37
Avg Time Held
6
quarters
Top 10 Avg Time Held
6.1
quarters
Top 20 Avg Time Held
4.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$11.8M |
| 2 |
Dominion Energy
D
|
+$8.67M |
| 3 |
Advanced Micro Devices
AMD
|
+$7.97M |
| 4 |
Tesla
TSLA
|
+$7.83M |
| 5 |
Broadcom
AVGO
|
+$7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Exelon
EXC
|
+$11M |
| 2 |
Sempra
SRE
|
+$9.56M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$8.68M |
| 4 |
Regency Centers
REG
|
+$8.65M |
| 5 |
Adobe
ADBE
|
+$7.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.41% |
| 2 | Consumer Discretionary | 14.27% |
| 3 | Healthcare | 11.61% |
| 4 | Financials | 10.56% |
| 5 | Communication Services | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1126
Opendoor
OPEN
$2.05B
| $131K | ﹤0.01% |
15,686
+479
| +3% | +$4.45K |
2021 Q2
3 quarters
|
|
1127
Sunstone Hotel Investors
SHO
$2.17B
| $122K | ﹤0.01% |
10,362
+70
| +0.7% | +$795 |
2021 Q2
3 quarters
|
|
1128
DELISTED
Amicus Therapeutics
FOLD
| $118K | ﹤0.01% |
12,507
-59
| -0.5% | -$553 |
2021 Q2
3 quarters
|
|
1129
DELISTED
Nikola Corporation Common Stock
NKLA
| $116K | ﹤0.01% |
361
+19
| +6% | +$4.85K |
2021 Q2
3 quarters
|
|
1130
Annaly Capital Management
NLY
$13.7B
| $114K | ﹤0.01% |
4,051
+238
| +6% | +$7.07K |
2021 Q2
3 quarters
|
|
1131
Firy Inc
FIRY
$206M
| $111K | ﹤0.01% |
1,843
+61
| +3% | +$4.97K |
2021 Q2
3 quarters
|
|
1132
FuelCell Energy
FCEL
$1.24B
| $101K | ﹤0.01% |
586
+7
| +1% | +$1.11K |
2021 Q2
3 quarters
|
|
1133
DELISTED
Tellurian Inc.
TELL
| $93K | ﹤0.01% |
17,557
+123
| +0.7% | +$414 |
2021 Q2
3 quarters
|
|
1134
Genworth Financial
GNW
$3.36B
| $91K | ﹤0.01% |
24,109
+195
| +0.8% | +$783 |
2020 Q2
7 quarters
|
|
|
TWO
1135
DELISTED
Two Harbors Investment
TWO
| $91K | ﹤0.01% |
4,099
+21
| +0.5% | +$457 |
2021 Q2
3 quarters
|
|
1136
NovaGold Resources
NG
$2.91B
| $87K | ﹤0.01% |
11,298
+75
| +0.7% | +$528 |
2021 Q2
3 quarters
|
|
1137
Claritev Corp
CTEV
$402M
| $73K | ﹤0.01% |
387
-64
| -14% | -$10.5K |
2021 Q2
3 quarters
|
|
1138
Opko Health
OPK
$985M
| $68K | ﹤0.01% |
19,743
+387
| +2% | +$1.37K |
2021 Q2
3 quarters
|
|
1139
SiriusXM
SIRI
$8.96B
| $67K | ﹤0.01% |
+1,007
| New | +$63.4K |
2022 Q1
0 quarters
|
|
1140
BGC Group
BGC
$5.43B
| $66K | ﹤0.01% |
15,050
+107
| +0.7% | +$473 |
2021 Q2
3 quarters
|
|
1141
Adamas Trust
ADAM
$685M
| $66K | ﹤0.01% |
4,517
+15
| +0.3% | +$219 |
2021 Q2
3 quarters
|
|
1142
Clear Channel Outdoor Holdings
CCO
$1.24B
| $60K | ﹤0.01% |
17,243
+123
| +0.7% | +$418 |
2021 Q2
3 quarters
|
|
1143
Uranium Energy
UEC
$4.08B
| $58K | ﹤0.01% |
12,561
+455
| +4% | +$1.67K |
2021 Q2
3 quarters
|
|
1144
Coeur Mining
CDE
$16.7B
| $54K | ﹤0.01% |
12,149
+80
| +0.7% | +$381 |
2021 Q2
3 quarters
|
|
1145
DELISTED
Immunogen Inc
IMGN
| $49K | ﹤0.01% |
+10,216
| New | +$56.6K |
2022 Q1
0 quarters
|
|
1146
Globalstar
GSAT
$10.7B
| $43K | ﹤0.01% |
1,930
+4
| +0.2% | +$68 |
2021 Q2
3 quarters
|
|
1147
MannKind Corp
MNKD
$981M
| $43K | ﹤0.01% |
11,744
+119
| +1% | +$435 |
2021 Q2
3 quarters
|
|
1148
Senseonics Holdings Inc
SENS
$472M
| $40K | ﹤0.01% |
1,028
+10
| +1% | +$458 |
2021 Q2
3 quarters
|
|
1149
Bionano Genomics
BNGO
$16M
| $36K | ﹤0.01% |
23
| – | – |
2021 Q2
3 quarters
|
|
1150
Diversified Healthcare Trust
DHC
$1.85B
| $36K | ﹤0.01% |
11,292
+78
| +0.7% | +$238 |
2021 Q2
3 quarters
|
|
Similar funds
PCM
LPC
MFG
PAM
BS
BBVA
NMO
PAS
Xponance's Q1 2022 Portfolio in Review
As of Q1 2022, Xponance held 1,204 positions worth $6.01B, down 5.7% from $6.37B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Xponance's Q1 2022 filing shows 32 new, 655 increased, 474 reduced and 37 closed positions. Its largest new stake was Apollo Global Management: 28,803 shares worth $1.78M. The largest sale was Exelon, an estimated $11M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Xponance's largest Q1 2022 buy was Apollo Global Management: 28,803 shares worth $1.78M.
- Xponance added most to Prologis in Q1 2022, an estimated $11.8M increase.
- Xponance's biggest Q1 2022 reduction was Exelon, cutting an estimated $11M.
- Xponance fully exited Xilinx Inc in Q1 2022, selling an estimated $8.68M.
- Xponance's ten largest holdings make up 35% of its $6.01B portfolio in Q1 2022.
- Xponance opened 32 new positions and closed 37 in Q1 2022.
- Xponance's portfolio value fell 5.7% quarter-over-quarter to $6.01B.
Based on Xponance's 13F filing for Q1 2022, filed 20 Apr 2022.